These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1394 related items for PubMed ID: 23763360

  • 1. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Verma S, Jensen D, Hart J, Mohanty SR.
    Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
    [Abstract] [Full Text] [Related]

  • 2. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP, Xun YH, Hu CB, Zhang L, Liu H, Lou GQ, Fan JG.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [Abstract] [Full Text] [Related]

  • 3. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S, Stewart SF, Henderson E, Burt AD, Day CP.
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
    Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ.
    Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
    [Abstract] [Full Text] [Related]

  • 8. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S.
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [Abstract] [Full Text] [Related]

  • 9. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients.
    Francque SM, Verrijken A, Mertens I, Hubens G, Van Marck E, Pelckmans P, Michielsen P, Van Gaal L.
    Clin Gastroenterol Hepatol; 2012 Oct; 10(10):1162-8; quiz e87. PubMed ID: 22796457
    [Abstract] [Full Text] [Related]

  • 10. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
    Wong VW, Wong GL, Tsang SW, Hui AY, Chan AW, Choi PC, Chim AM, Chu S, Chan FK, Sung JJ, Chan HL.
    Aliment Pharmacol Ther; 2009 Feb 15; 29(4):387-96. PubMed ID: 19035982
    [Abstract] [Full Text] [Related]

  • 11. Stepwise combination of simple noninvasive fibrosis scoring systems increases diagnostic accuracy in nonalcoholic fatty liver disease.
    Demir M, Lang S, Nierhoff D, Drebber U, Hardt A, Wedemeyer I, Schulte S, Quasdorff M, Goeser T, Töx U, Steffen HM.
    J Clin Gastroenterol; 2013 Sep 15; 47(8):719-26. PubMed ID: 23442837
    [Abstract] [Full Text] [Related]

  • 12. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.
    Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L, Zein NN, Feldstein AE.
    Liver Int; 2012 Feb 15; 32(2):297-302. PubMed ID: 22097893
    [Abstract] [Full Text] [Related]

  • 13. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
    Alkhouri N, Sedki E, Alisi A, Lopez R, Pinzani M, Feldstein AE, Nobili V.
    Liver Int; 2013 Jan 15; 33(1):79-85. PubMed ID: 23146095
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values.
    Amarapurkar DN, Patel ND.
    Trop Gastroenterol; 2004 Jan 15; 25(3):130-4. PubMed ID: 15682660
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z, Xu M, Peng J, Jiang L, Hu Z, Wang H, Zhou S, Zhou R, Hultström M, Lai EY.
    Exp Gerontol; 2013 Aug 15; 48(8):705-9. PubMed ID: 23721951
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.
    Obes Surg; 2005 Mar 15; 15(3):310-5. PubMed ID: 15826462
    [Abstract] [Full Text] [Related]

  • 20. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).
    Tasneem AA, Luck NH, Majid Z.
    Trop Doct; 2018 Apr 15; 48(2):107-112. PubMed ID: 29145775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.